New training aims to improve mental health care for new moms

NCT ID NCT07098260

Recruiting now Knowledge-focused Sponsor: Rutgers, The State University of New Jersey Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a training program called DECIDE for MOM, designed to help healthcare providers better support pregnant and postpartum individuals with mental health concerns. The training teaches skills like shared decision-making and understanding patients' perspectives. Researchers will enroll 35 providers and ask them to complete a 2-hour online course, then give feedback on how acceptable and useful the training is. The goal is to see if this training can be widely used to improve maternal mental health care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: DECIDE for MOM Provider Training (behavioral intervention)
What this could lead to: If successful, this training could improve how providers communicate with pregnant and postpartum individuals about mental health, leading to better care decisions.
What could go wrong: This is a small, early-stage study with only 35 participants, focused on provider training rather than patient outcomes. It may not show clear benefits or be scalable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MENTAL HEALTH DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

mental disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MENTAL HEALTH DISORDERS

Contacts and locations

Locations

Rutgers, the State University of New Jersey
RECRUITING

Piscataway, New Jersey, 08854, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.